| Alison Lemke, | |
|
751 Route 37 W, Toms River, NJ 08755-5032 | |
| (848) 224-4578 | |
| (848) 224-4276 |
| Full Name | Alison Lemke |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Addiction (substance Use Disorder) |
| Location | 751 Route 37 W, Toms River, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003455650 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WA0400X | Registered Nurse - Addiction (substance Use Disorder) | 26NO09787700 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alison Lemke, 751 Route 37 W, Toms River, NJ 08755-5032 Ph: (848) 224-4578 | Alison Lemke, 751 Route 37 W, Toms River, NJ 08755-5032 Ph: (848) 224-4578 |
News Archive
A new study from Rhode Island Hospital has found a significant increase in the occurrence of methicillin-resistant Staphylococcus aureus infections in the summer and autumn months.
Following five days of deliberations aimed at fleshing-out the so-called Framework Convention for Tobacco Control, delegates on Saturday approved a proposal to limit the use of tobacco additives, which critics say improve the flavor of cigarettes, encouraging consumers to smoke more, Reuters reports.
In an effort to better define sexual dysfunction after urethroplasty for anterior strictures, a recent study was performed by Chris Gonzalez and colleagues from Northwestern University in Chicago. The paper is published in the March 2007 issue of BJU International.
A screening test that measures whether a patient's heart is healthy enough for a kidney transplant is not as dangerous as once thought, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
AbbVie, a global biopharmaceutical company, today announced that it will advance ABT-494, its internally developed investigational selective JAK1 inhibitor, to Phase 3 studies in rheumatoid arthritis. Following a thorough review of available data, AbbVie will not exercise its right to in-license the Galapagos JAK1 inhibitor, filgotinib.
› Verified 1 days ago
Marisol Flores-carino, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 717 Woodchuck Ln, Toms River, NJ 08755 Phone: 732-300-7806 | |
Shiron White, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 431 Applegate Ave, Toms River, NJ 08757 Phone: 718-290-7015 | |
Adina Lerer, FNP-C, RN, IBCLC Registered Nurse Medicare: Medicare Enrolled Practice Location: 1801 Charlton Cir, Toms River, NJ 08755 Phone: 347-420-2824 | |
Patricia D Saveriano, NP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 111 West Water Street, Toms River, NJ 08753 Phone: 732-244-4700 Fax: 732-244-8482 | |
Miss Janet A. Pesce, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 324 Maine St, Toms River, NJ 08753 Phone: 732-255-8791 | |
Mrs. Emily Sarah Ciaccio, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 99 Nj Route 37, Toms River, NJ 08755 Phone: 732-557-8000 |